Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy

By López Eugenio   Gunby Joanne   Daya Salim   Parrilla Juan J   Abad Lorenzo   Balasch Juan  

Reproductive BioMedicine Online, Vol. 9, Iss. 4, 2004-10 ,pp. : 382-390

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA

By Silverberg K   Schertz J   Falk B   Beresniak A  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 265-269

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

HMG versus rFSH for ovulation induction in developing countries: a cost–effectiveness analysis based on the results of a recent meta-analysis

By Al-Inany Hesham G   Abou-Setta Ahmed M   Aboulghar Mohamed A   Mansour Ragaa T   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 163-169

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome

By Lan VTN   Norman RJ   Nhu GH   Tuan PH   Tuong HM  

Reproductive BioMedicine Online, Vol. 18, Iss. 4, 2009-04 ,pp. : 516-521

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI

By Kolibianakis Efstratios   Zikopoulos Kostantinos   Albano Carola   Camus Michel   Tournaye Herman   Van Steirteghem Andre   Devroey Paul  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 313-318

Reproductive Healthcare Ltd

Access to resources Recommend Favorite